Drugs / Omega-DEK
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07216001 | May 2026 → Dec 2027 expected | autism, childhood apraxia of speech | Claudia R. Morris | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Omega-DEK | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07216001 ↗ |